Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
European Journal of Cardiovascular Nursing|August 26, 2023
Development and validation of osteoporosis risk assessment score in patients with heart failure: comparison with the osteoporosis self-assessment tool for AsiansRyo Numazawa, Satoshi Katano, Toshiyuki Yano, et al.
ESC Heart Failure|May 18, 2021
Does renin-angiotensin system inhibition have impacts on muscle mass and bone mineral density in heart failure patients?Satoshi Katano, Toshiyuki Yano, Masaki Shimizu, et al.
ESC Heart Failure|December 13, 2023
Relationship between serum iron level and physical function in heart failure patients is lost by presence of diabetesKatsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.
ESC Heart Failure|May 5, 2024
Associations between in-hospital daily protein intake and adverse clinical outcomes in older patients with heart failureSatoshi Katano, Toshiyuki Yano, Kotaro Yamano, et al.
Diabetes Care|August 31, 2004
Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetesMasato Furuhashi, Nobuyuki Ura, Norihito Moniwa, et al.
ESC Heart Failure|September 6, 2021
Plasma amino acid profiling improves predictive accuracy of adverse events in patients with heart failureHidemichi Kouzu, Satoshi Katano, Toshiyuki Yano, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 10, 2019
mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activationKoki Abe, Toshiyuki Yano, Masaya Tanno, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 26, 2026
Exploring a Subpopulation of MASLD Associated With New Onset of CKD Using Supervised Clustering TechniquesItaru Hosaka, Marenao Tanaka, Tatsuya Sato, et al.
Journal of Diabetes|July 18, 2020
Distinct determinants of muscle wasting in nonobese heart failure patients with and without type 2 diabetes mellitusToshiyuki Yano, Satoshi Katano, Hidemichi Kouzu, et al.
Pageof 9